Findings

What do systematic reviews say?

117 questions · 121 findings · 39 reviews · Urology

Sort:Best matchNewest Highest certainty Download CSV

No studies found 60 · 49.6%GRADE not reported 1 · 0.8%Very low 7 · 5.8%Low 26 · 21.5%Moderate 25 · 20.7%High 2 · 1.7%

Injectional nicardipine vs Normal saline

Quality of life · men with chronic Peyronie's disease (plaques without calcification)

The review found no eligible studies for this question.

1 finding from 1 review

Non‐surgical therapies for Peyronie's disease 2023 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Injectional betamethasone vs Normal saline

Quality of life · men with Peyronie's disease (not defined)

The review found no eligible studies for this question.

1 finding from 1 review

Non‐surgical therapies for Peyronie's disease 2023 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Injectional collagenase vs placebo

Quality of life · men with Peyronie's disease (diagnosis of disease: at least 12 months, penile curvature: at least 30 degrees)

2 findings from 1 review

Non‐surgical therapies for Peyronie's disease 2023 · Cochrane Headline outcomes only
no estimate extracted
1 study · 134 participants
Low
Non‐surgical therapies for Peyronie's disease 2023 · Cochrane Headline outcomes only
no estimate extracted
1 study · 612 participants
Moderate

Potassium paraaminobenzoate vs placebo

Quality of life · men with acute (maximum of 12 months) Peyronie's disease with no prior treatment and no evidence of calcified plaques (pain during…

The review found no eligible studies for this question.

1 finding from 1 review

Non‐surgical therapies for Peyronie's disease 2023 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Injectional verapamil vs saline (short‐term)

Quality of life · men with Peyronie's disease (palpable plaque or pain)

The review found no eligible studies for this question.

1 finding from 1 review

Non‐surgical therapies for Peyronie's disease 2023 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Injectional Botox vs placebo

Quality of life · men with Peyronie's disease (stable phase)

1 finding from 1 review

Non‐surgical therapies for Peyronie's disease 2023 · Cochrane Headline outcomes only
no estimate extracted
1 study · 12 participants
Very low

Extracorporeal shockwave therapy vs sham

Quality of life · men with Peyronie's disease (palpable plaque or pain)

1 finding from 1 review

Non‐surgical therapies for Peyronie's disease 2023 · Cochrane Headline outcomes only
no estimate extracted
2 studies · 130 participants
Low

Penile traction therapy vs no treatment (short‐term)

Quality of life · men with Peyronie's disease (diagnosis of disease: varying, penile curvature: at least 30 degrees)

1 finding from 1 review

Non‐surgical therapies for Peyronie's disease 2023 · Cochrane Headline outcomes only
no estimate extracted
1 study · 82 participants
Very low

Injectional interferon alpha‐2B vs Normal saline

Quality of life · men with chronic (≥ 12 months) Peyronie's disease (single plaque)

The review found no eligible studies for this question.

1 finding from 1 review

Non‐surgical therapies for Peyronie's disease 2023 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Dose‐escalated RT vs conventional dose RT

Quality of life · clinically localized and locally advanced prostate cancer

1 finding from 1 review

Dose‐escalated radiotherapy for clinically localized and locally advanced prostate cancer 2023 · Cochrane Headline outcomes only
no estimate extracted
1 study · 300 participants
Moderate

Intervention not reported

Quality of life · people with a confirmed diagnosis of advanced renal cell carcinoma (RCC) and a favourable risk according to the International Metastatic…

The review found no eligible studies for this question.

1 finding from 1 review

First‐line therapy for adults with advanced renal cell carcinoma: a systematic review and network meta‐analysis 2023 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Intervention not reported

Quality of life · people with a confirmed diagnosis of advanced renal cell carcinoma (RCC) and an intermediate or poor risk according to the International…

The review found no eligible studies for this question.

1 finding from 1 review

First‐line therapy for adults with advanced renal cell carcinoma: a systematic review and network meta‐analysis 2023 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

PAE vs sham

Quality of life · men with lower urinary tract symptoms suggesting benign prostatic hyperplasia

1 finding from 1 review

Prostatic arterial embolization for the treatment of lower urinary tract symptoms in men with benign prostatic… 2022 · Cochrane Headline outcomes only
no estimate extracted
1 study · 80 participants
Moderate

PAE vs TURP

Quality of life

1 finding from 1 review

Prostatic arterial embolization for the treatment of lower urinary tract symptoms in men with benign prostatic… 2022 · Cochrane Headline outcomes only
no estimate extracted
2 studies · 176 participants
Low

Transurethral microwave thermotherapy vs transurethral resection of the prostate

Quality of life · men with lower urinary tract symptoms secondary to benign prostatic obstruction

1 finding from 1 review

Transurethral microwave thermotherapy for the treatment of lower urinary tract symptoms in men with benign prostatic… 2021 · Cochrane Headline outcomes only
no estimate extracted
1 study · 136 participants
Moderate

Transurethral microwave thermotherapy vs sham

Quality of life · men with lower urinary tract symptoms secondary to benign prostatic obstruction

1 finding from 1 review

Transurethral microwave thermotherapy for the treatment of lower urinary tract symptoms in men with benign prostatic… 2021 · Cochrane Headline outcomes only
no estimate extracted
2 studies · 347 participants
Low

Degarelix vs standard androgen suppression therapy

Quality of life · hormone‐sensitive prostate cancer

1 finding from 1 review

Degarelix for treating advanced hormone‐sensitive prostate cancer 2021 · Cochrane Headline outcomes only
no estimate extracted
3 studies · 2887 participants
Moderate

Radical prostatectomy vs watchful waiting

Quality of life · clinically localized prostate cancer

Radical prostatectomy showed no clear difference in quality of life compared with watchful waiting (low certainty).

1 finding from 1 review

Radical prostatectomy versus deferred treatment for localised prostate cancer 2020 · Cochrane Headline outcomes only
RR 1 [0.85, 1.16]
1 study · 339 participants
Low

Convective radiofrequency water vapour thermal therapy vs sham

Quality of life · men with lower urinary tract symptoms suggesting benign prostatic hyperplasia

1 finding from 1 review

Convective radiofrequency water vapour thermal therapy for lower urinary tract symptoms in men with benign prostatic… 2020 · Cochrane Headline outcomes only
no estimate extracted
1 study · 195 participants
Moderate

Alpha‐blocker as adjuvant medical expulsive therapy plus usual care vs usual care

Quality of life · adults with renal and ureteral stones undergoing shock wave lithotripsy

The review found no eligible studies for this question.

1 finding from 1 review

Alpha‐blockers after shock wave lithotripsy for renal or ureteral stones in adults 2020 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found